MDM2 and hepatocellular carcinoma: In human hepatocellular carcinoma, HA22T cells treated with diosmin showed promising inhibitory effects on viability and proliferation by modulating PI3K‐AKT/MDM2 signaling pathways and p53, the downstream factors of the phosphate 2A (PP2A) protein (Dung et al., 2012).